Israel Englander Novavax Inc Transaction History

Millennium Management LLC

$192 Billion
Q4 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Novavax Inc stock. As of the latest transaction made, Millennium Management LLC holds 1,001,433 shares of NVAX stock, worth $7.88 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,001,433

Previous 150,000 567.62%

Holding current value

$7.88 Million

Previous $1.89 Million 325.08%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2024 Feb 14, 2025	SELL	$7.22 - $14.68 $5.71 Million - $11.6 Million	-791,408 Reduced 44.14%	1,001,433 $8.05 Million
Q3 2024 Nov 14, 2024	BUY	$10.71 - $17.11 $16.5 Million - $26.3 Million	1,538,063 Added 603.69%	1,792,841 $22.6 Million
Q2 2024 Aug 14, 2024	BUY	$3.89 - $20.97 $889,059 - $4.79 Million	228,550 Added 871.4%	254,778 $3.23 Million
Q1 2024 May 15, 2024	SELL	$3.76 - $6.02 $1.48 Million - $2.37 Million	-394,198 Reduced 93.76%	26,228 $125,000
Q4 2023 Feb 14, 2024	BUY	$4.8 - $7.67 $1.72 Million - $2.75 Million	358,160 Added 575.21%	420,426 $2.02 Million
Q2 2023 Aug 14, 2023	BUY	$6.67 - $9.52 $80,100 - $114,325	12,009 Added 23.9%	62,266 $462,000
Q1 2023 May 15, 2023	SELL	$5.76 - $12.48 $8.64 Million - $18.7 Million	-1,500,405 Reduced 96.76%	50,257 $348,000
Q4 2022 Feb 14, 2023	BUY	$8.86 - $25.04 $9.07 Million - $25.6 Million	1,023,328 Added 194.06%	1,550,662 $15.9 Million
Q3 2022 Nov 14, 2022	SELL	$18.2 - $76.12 $6.23 Million - $26 Million	-342,076 Reduced 39.35%	527,334 $9.6 Million
Q2 2022 Aug 15, 2022	BUY	$36.28 - $75.29 $9.2 Million - $19.1 Million	253,477 Added 41.15%	869,410 $44.7 Million
Q1 2022 May 16, 2022	BUY	$69.73 - $142.9 $42.5 Million - $87.1 Million	609,312 Added 9202.72%	615,933 $45.4 Million
Q4 2021 Feb 14, 2022	SELL	$134.56 - $217.97 $24.7 Million - $40 Million	-183,328 Reduced 96.51%	6,621 $947,000
Q3 2021 Nov 15, 2021	SELL	$177.8 - $270.58 $23.9 Million - $36.4 Million	-134,573 Reduced 41.47%	189,949 $39.4 Million
Q2 2021 Aug 16, 2021	SELL	$121.0 - $257.67 $4.75 Million - $10.1 Million	-39,244 Reduced 10.79%	324,522 $68.9 Million
Q1 2021 May 17, 2021	BUY	$112.98 - $319.93 $20.7 Million - $58.6 Million	183,245 Added 101.51%	363,766 $66 Million
Q4 2020 Feb 16, 2021	SELL	$78.74 - $139.5 $10.1 Million - $18 Million	-128,760 Reduced 41.63%	180,521 $20.1 Million
Q3 2020 Nov 16, 2020	BUY	$79.44 - $178.51 $12 Million - $27 Million	151,213 Added 95.66%	309,281 $33.5 Million
Q2 2020 Aug 14, 2020	SELL	$13.86 - $83.61 $6.55 Million - $39.5 Million	-472,646 Reduced 74.94%	158,068 $13.2 Million
Q1 2020 May 14, 2020	BUY	$3.93 - $16.0 $2.4 Million - $9.76 Million	609,860 Added 2924.43%	630,714 $8.57 Million
Q4 2019 Feb 14, 2020	BUY	$3.69 - $5.22 $25,579 - $36,185	6,932 Added 49.79%	20,854 $83,000
Q3 2019 Nov 14, 2019	BUY	$4.02 - $7.84 $5,833 - $11,375	1,451 Added 11.63%	13,922 $69,000
Q2 2019 Aug 14, 2019	BUY	$4.93 - $12.2 $61,482 - $152,146	12,471 New	12,471 $73,000

Others Institutions Holding NVAX

# of Institutions

285

Shares Held

93.8M

Call Options Held

5.4M

Put Options Held

8.76M

View Full List

About NOVAVAX INC

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $616M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

More about NVAX

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account